← Back to Discover
Andera Partners
Period ended Sep 30, 2026 · Latest filing Oct 16, 2026
These quarterly holdings are delayed and may not include all assets or short positions.
Values are from the reporting date, not current prices or purchase costs.
The same security may appear in multiple rows.
Source: SEC
Reported portfolio value
Quarter-end reported holdings; not current value or investment performance.
View reported values
- Sep 30, 2026: $175,700,568
More quarters will appear as history becomes available.
Top holdings
Top 10 at Sep 30, 2026. Matching entries are combined; security classes and options remain separate. Shares exclude principal amounts; option shares reflect the reported underlying amount.
View top holdings values
- KESTRA MED TECHNOLOGIES LTD · SHS · G52441105 · shares: $77,194,329
- MINERALYS THERAPEUTICS INC · COM · 603170101 · shares: $40,004,874
- AVALYN PHARMACEUTICALS INC · COM SHS · 05348Y105 · shares: $26,490,686
- AGOMAB THERAPEUTICS NV · SPONSORED ADS · 00860C102 · shares: $17,079,592
- INVENTIVA SA · ADS · 46124U107 · shares: $13,406,438
- EVOMMUNE INC · COM SHS · 30054Y107 · shares: $804,210
- NYXOAH S A · SHS · B6S7WD106 · shares: $720,439
Reported holdings
7 reported entries| Issuer | Class | CUSIP | Type | Shares / principal | Reported value (USD) |
|---|---|---|---|---|---|
| KESTRA MED TECHNOLOGIES LTD | SHS | G52441105 | — | 2,728,679 shares | $77,194,329 |
| MINERALYS THERAPEUTICS INC | COM | 603170101 | — | 1,591,917 shares | $40,004,874 |
| AVALYN PHARMACEUTICALS INC | COM SHS | 05348Y105 | — | 929,824 shares | $26,490,686 |
| AGOMAB THERAPEUTICS NV | SPONSORED ADS | 00860C102 | — | 1,538,702 shares | $17,079,592 |
| INVENTIVA SA | ADS | 46124U107 | — | 3,633,181 shares | $13,406,438 |
| EVOMMUNE INC | COM SHS | 30054Y107 | — | 97,362 shares | $804,210 |
| NYXOAH S A | SHS | B6S7WD106 | — | 522,057 shares | $720,439 |